Health Sciences Acquisiti... (HSAQ)
NASDAQ: HSAQ
· Real-Time Price · USD
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 9:59 PM
Health Sciences Acquisitions 2 Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -103.63M | -84.27M | -65.51M | -15.43M | -11.82M | -12.5M | -13.24M | -2.74M | -2.05M | -1.46M | -816.44K | -486.75K | -290.92K | -200.5K | -108.18K |
Depreciation & Amortization | 477K | 396K | 313K | 76K | 71K | 71K | 71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 17.7M | 14.46M | 11.49M | 2.36M | 1.49M | 1.49M | 1.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.87M | -2.87M | -2.87M | -1.14M | 1.95M | 2.08M | 2.64M | 922.17K | 743.6K | 596.69K | 113.4K | 114.07K | 57.53K | 73.41K | 1.01K |
Other Non-Cash Items | 2.93M | 2.43M | 3.34M | 523K | -3.27M | -3.4M | -3.4M | -141.89K | -114.3K | 9.29K | 5.31K | 15.63K | -2.31M | -2.31M | -2.31M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 494K | 494K | 494K | -1.24M | -1.41M | -1.17M | -549.66K | 1.3M | 1.04M | 768.76K | 203.19K | 122.39K | 2.1M | 2.14M | 2.08M |
Operating Cash Flow | -82.02M | -66.49M | -49.88M | -13.7M | -14.94M | -15.51M | -15.62M | -1.58M | -1.12M | -680.98K | -607.94K | -348.74K | -502.04K | -374.02K | -334.88K |
Capital Expenditures | -468K | -434K | -322K | -68K | -35K | -35K | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -602K | -602K | -602K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -42.04M | -42.04M | -39.14M | -9.99M | -43.49M | -43.49M | -43.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 129.64M | 113.25M | 97.24M | 10.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 92.59M | 92.59M | 92.59M | 92.59M | n/a | n/a | n/a | n/a | -160M | -160M | -160M |
Investing Cash Flow | 86.53M | 70.17M | 57.17M | 557K | 49.06M | 49.06M | 49.06M | 92.59M | n/a | n/a | n/a | n/a | -160M | -160M | -160M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -13.34M | -12.91M | -12.62M | 15.04M | -35.77M | -35.77M | -35.77M | -92.59M | n/a | n/a | n/a | n/a | 162.29M | 162.29M | 162.29M |
Financial Cash Flow | -13.34M | -12.91M | -12.62M | 15.04M | -35.77M | -35.77M | -35.77M | -92.59M | n/a | n/a | n/a | n/a | 162.29M | 162.29M | 162.29M |
Net Cash Flow | -1.62M | -2.02M | 1.89M | 1.89M | -1.65M | -2.22M | -2.33M | -1.58M | -1.05M | -604.6K | -531.57K | -272.36K | -254.51K | -126.5K | -87.36K |
Free Cash Flow | -82.49M | -66.93M | -50.2M | -13.77M | -14.98M | -15.55M | -15.66M | -1.58M | -1.12M | -680.98K | -607.94K | -348.74K | -502.04K | -374.02K | -334.88K |